First Look: Benchling’s Biotech AI 2026 Report
What the industry must know before JPM Healthcare Week
Join us for an exclusive first look at Benchling’s Biotech AI 2026 Report, the clearest picture yet of how 100 biotech AI frontrunners are translating AI into real scientific impact.
Benchling co-founder and Head of AI Ashu Singhal will share a rare, insider's view of what the most advanced biotech teams are really doing with AI — the stages of the R&D lifecycle where it’s delivering impact today, the use cases gaining traction or stalling out, and how leaders are preparing for automation, multimodal models, and closed-loop systems.
Where AI is already delivering measurable scientific gains today: New industry data on speed gains, hit-rate improvements, and where AI works best across discovery and development.
Why AI keeps hitting a wall in complex science: The “clean-data ceiling”: how fragmented data, incomplete wet-dry lab connections, and compliance constraints block higher-value AI use cases — and what leaders are changing in their infrastructure to break through.
The next wave of AI in biotech: How organizations are planning for multimodal models, autonomous agents, cross-team workflow orchestration, and AI-ready lab automation over the next 1-2 years.
Tech maturity as the new R&D KPI: Why 2026 will be the first year biopharma is judged as much by its technical infrastructure as its pipeline progress.
A behind-the-scenes perspective from Ashu: Insights from working with Benchling customers, deploying AI copilots and agents, and building the underlying platform for AI-native science.
Register now
You're registered
Thank you for registering. We'll email you a calendar invite along with the details.
